The Promise of Scientific Partnerships with People on the Spectrum

Five collaborations involving autistic scientists and experts are advancing autism research, from lending support for theories of the condition to shoring up trials of new treatments.

Written byLaura Dattaro and Spectrum
| 15 min read

Register for free to listen to this article
Listen with Speechify
0:00
15:00
Share

ABOVE: ILLUSTRATION BY CINYEE CHIU

For years, systems scientist Dora Raymaker and physician Christina Nicolaidis have spent Thanksgiving, Christmas and New Year’s Eve together. Though they are not exactly family, they are close, both figuratively and (in pre-pandemic times) literally: They are research collaborators, and their offices at Portland State University in Oregon are next to each other. Raymaker, who is autistic, and Nicolaidis, who is not, are best friends and use the same words to describe their connection: “We share a brain.”

Partnerships like that of the Portland pair are key to advancing autism research. In addition to the bond between Raymaker and Nicolaidis, what makes the collaboration work is that their brains are not the same. Raymaker brings a perspective to their projects that is different from that of a non-autistic person, and she acts as a bridge between the autism and research communities. To Nicolaidis, Raymaker’s input ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Laura Dattaro wears a white sweater in front of trees.

    Laura Dattaro is a freelance science and health journalist. Her recent work has been published in Drug Discovery News, Nature, Quanta, and The Washington Post, among other outlets. She also works as the administrator and communications manager for the Council for the Advancement of Science Writing. 

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies